Quest Diagnostics Income from Discontinued Operations 2010-2025 | DGX

Quest Diagnostics annual/quarterly income from discontinued operations history and growth rate from 2010 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
  • Quest Diagnostics income from discontinued operations for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Quest Diagnostics income from discontinued operations for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Quest Diagnostics annual income from discontinued operations for 2024 was $0B, a 0% decline from 2023.
  • Quest Diagnostics annual income from discontinued operations for 2023 was $0B, a 0% decline from 2022.
  • Quest Diagnostics annual income from discontinued operations for 2022 was $0B, a 0% decline from 2021.
Quest Diagnostics Annual Income from Discontinued Operations
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $20
2018 $0
2017 $0
2016 $0
2015 $0
2014 $5
2013 $35
2012 $-74
2011 $12
2010 $12
2009 $-1
Quest Diagnostics Quarterly Income from Discontinued Operations
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30 $20
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30 $2
2013-06-30 $13
2013-03-31 $20
2012-12-31 $-84
2012-09-30 $5
2012-06-30 $2
2012-03-31 $3
2011-12-31 $13
2011-09-30 $0
2011-06-30 $-1
2011-03-31 $0
2010-12-31 $13
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $1
2009-06-30 $0
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.715B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $11.983B 25.40
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.311B 15.66
Chemed (CHE) United States $6.894B 21.67
Option Care Health (OPCH) United States $5.081B 22.65
RadNet (RDNT) United States $4.175B 265.00
Amedisys (AMED) United States $3.149B 21.18
Addus HomeCare (ADUS) United States $2.031B 22.30
LifeStance Health (LFST) United States $1.857B 0.00
Astrana Health (ASTH) United States $1.382B 34.24
U.S Physical Therapy (USPH) United States $1.226B 31.64
Pennant (PNTG) United States $0.893B 32.78
Aveanna Healthcare Holdings (AVAH) United States $0.870B 49.56
Atai Life Sciences (ATAI) Germany $0.551B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.041B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00